Immune Thrombocytopenia Purpura (ITP)

The podcast addresses immune thrombocytopenia purpura (ITP), focusing on its definition, diagnosis, and treatment options for adult patients. Thrombocytopenia is defined as a platelet count below 150,000, with major bleeding risks increasing below 10,000. Diagnosing ITP involves excluding other causes of thrombocytopenia. Treatment ranges from corticosteroids as a first-line approach to second-line therapies like splenectomy, rituximab, and intravenous gamma globulin (IVIG). Newer treatments include thrombopoietin receptor agonists, such as romiplastim and eltrombopag, which stimulate platelet production but require continuous use and enrollment in a registry due to potential side effects and high costs. Platelet transfusions, while not ideal due to autoantibody destruction, are advocated in life-threatening emergencies, especially when combined with IVIG.